vs
Side-by-side financial comparison of HARTE HANKS INC (HHS) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $39.9M, roughly 1.2× HARTE HANKS INC). HARTE HANKS INC runs the higher net margin — 5.5% vs -33.9%, a 39.4% gap on every dollar of revenue. On growth, HARTE HANKS INC posted the faster year-over-year revenue change (-15.4% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs -6.4%).
Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
HHS vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.9M | $47.1M |
| Net Profit | $2.2M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | -0.3% | -17.7% |
| Net Margin | 5.5% | -33.9% |
| Revenue YoY | -15.4% | -15.6% |
| Net Profit YoY | — | 68.8% |
| EPS (diluted) | $0.30 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.9M | $47.1M | ||
| Q3 25 | $39.5M | $38.2M | ||
| Q2 25 | $38.6M | $38.4M | ||
| Q1 25 | $41.6M | $32.5M | ||
| Q4 24 | $47.1M | $55.8M | ||
| Q3 24 | $47.6M | $29.3M | ||
| Q2 24 | $45.0M | $34.0M | ||
| Q1 24 | $45.4M | $25.5M |
| Q4 25 | $2.2M | $-16.0M | ||
| Q3 25 | $-2.3M | $-23.8M | ||
| Q2 25 | $-335.0K | $202.5M | ||
| Q1 25 | $-392.0K | $-25.0M | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | $142.0K | $-148.3M | ||
| Q2 24 | $-27.8M | $-582.3M | ||
| Q1 24 | $-171.0K | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | -0.3% | -17.7% | ||
| Q3 25 | 1.3% | -33.6% | ||
| Q2 25 | 0.1% | -34.8% | ||
| Q1 25 | -0.1% | -65.0% | ||
| Q4 24 | -3.3% | -84.4% | ||
| Q3 24 | 4.0% | -493.2% | ||
| Q2 24 | 3.0% | -1705.5% | ||
| Q1 24 | 0.8% | -267.0% |
| Q4 25 | 5.5% | -33.9% | ||
| Q3 25 | -5.8% | -62.2% | ||
| Q2 25 | -0.9% | 527.8% | ||
| Q1 25 | -0.9% | -76.9% | ||
| Q4 24 | — | -91.6% | ||
| Q3 24 | 0.3% | -506.3% | ||
| Q2 24 | -61.8% | -1712.6% | ||
| Q1 24 | -0.4% | -283.9% |
| Q4 25 | $0.30 | $-4.40 | ||
| Q3 25 | $-0.31 | $-2.84 | ||
| Q2 25 | $-0.05 | $-1.79 | ||
| Q1 25 | $-0.05 | $-0.15 | ||
| Q4 24 | $-0.31 | $-15.29 | ||
| Q3 24 | $0.02 | $-18.24 | ||
| Q2 24 | $-3.84 | $-71.81 | ||
| Q1 24 | $-0.02 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.6M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $20.5M | $-249.4M |
| Total Assets | $91.8M | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $48.9M | ||
| Q3 25 | $6.5M | $43.1M | ||
| Q2 25 | $4.8M | $40.8M | ||
| Q1 25 | $9.0M | $58.6M | ||
| Q4 24 | $9.8M | $56.3M | ||
| Q3 24 | $5.9M | $75.4M | ||
| Q2 24 | $11.0M | $89.6M | ||
| Q1 24 | $11.5M | $112.8M |
| Q4 25 | $20.5M | $-249.4M | ||
| Q3 25 | $19.9M | $-235.7M | ||
| Q2 25 | $22.2M | $-214.1M | ||
| Q1 25 | $21.4M | $-417.5M | ||
| Q4 24 | $21.7M | $-398.4M | ||
| Q3 24 | $21.0M | $-344.1M | ||
| Q2 24 | $20.6M | $-203.2M | ||
| Q1 24 | $20.0M | $371.6M |
| Q4 25 | $91.8M | $308.9M | ||
| Q3 25 | $92.7M | $362.6M | ||
| Q2 25 | $95.0M | $379.2M | ||
| Q1 25 | $100.6M | $405.1M | ||
| Q4 24 | $101.8M | $437.4M | ||
| Q3 24 | $108.1M | $537.8M | ||
| Q2 24 | $109.7M | $691.5M | ||
| Q1 24 | $113.4M | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $737.0K | $8.2M |
| Free Cash FlowOCF − Capex | $-686.0K | — |
| FCF MarginFCF / Revenue | -1.7% | — |
| Capex IntensityCapex / Revenue | 3.6% | — |
| Cash ConversionOCF / Net Profit | 0.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-4.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $737.0K | $8.2M | ||
| Q3 25 | $3.2M | $11.4M | ||
| Q2 25 | $-4.8M | $-21.3M | ||
| Q1 25 | $-818.0K | $8.5M | ||
| Q4 24 | $4.0M | $-14.7M | ||
| Q3 24 | $-2.9M | $-9.4M | ||
| Q2 24 | $1.6M | $-11.9M | ||
| Q1 24 | $-5.7M | $-621.0K |
| Q4 25 | $-686.0K | — | ||
| Q3 25 | $2.2M | — | ||
| Q2 25 | $-5.1M | — | ||
| Q1 25 | $-923.0K | — | ||
| Q4 24 | $3.4M | — | ||
| Q3 24 | $-4.9M | — | ||
| Q2 24 | $926.0K | — | ||
| Q1 24 | $-6.2M | — |
| Q4 25 | -1.7% | — | ||
| Q3 25 | 5.5% | — | ||
| Q2 25 | -13.1% | — | ||
| Q1 25 | -2.2% | — | ||
| Q4 24 | 7.3% | — | ||
| Q3 24 | -10.2% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | -13.7% | — |
| Q4 25 | 3.6% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 1.3% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.2% | — |
| Q4 25 | 0.33× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -20.76× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HHS
| Fulfillment And Logistics Services | $17.3M | 43% |
| Customer Care | $13.7M | 34% |
| Other | $8.9M | 22% |
STEM
Segment breakdown not available.
